RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy17277
         (123 letters)



>gnl|CDD|212040 cd10332, SLC6sbd-B0AT-like, System B(0) neutral amino acid
           transporter AT1, 2 and 3, and related proteins;
           solute-binding domain.  This subgroup includes the
           solute-binding domain of transmembrane transporters,
           which transport, i) neutral amino acids: NTT4 (also
           called XT1), SBAT1 (also called B0AT2, v7-3, NTT7-3),
           and B0AT1 (also called HND); the human genes encoding
           these are SLC6A17, SLC6A15, and SLC6A19 respectively,
           ii) glycine: B0AT3 (also called Xtrp2, XT2), iii) imino
           acids, such as proline, pipecolate, MeAIB, and
           sarcosine: SIT1 (also called XTRP3, XT3, IMINO). The
           human genes encoding B0AT3 and SIT1 are SLC6A18 and
           SLC6A20 respectively. Transporters in this subgroup may
           play a role in disorders including major depression,
           Hartnup disorder, increased susceptibility to myocardial
           infarction, and iminoglycinuria. This subgroup belongs
           to the solute carrier 6 (SLC6) transporter family.
          Length = 565

 Score =  192 bits (491), Expect = 5e-60
 Identities = 73/123 (59%), Positives = 90/123 (73%)

Query: 1   MAATASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKI 60
           +     GTGLAFI+FTEAI +FPGA  W+VLFFLML TLG+ S FGTLEGV T + D KI
Sbjct: 354 LDEAVEGTGLAFIVFTEAIVKFPGAPFWSVLFFLMLLTLGLGSMFGTLEGVLTPLFDSKI 413

Query: 61  FPNMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIY 120
            P + KE +TG++CL+C +I + F   +GNY   +FDS+SG  PLLIIA FE IAVSY+Y
Sbjct: 414 LPKVPKEYLTGLVCLVCFLIGLIFTQRSGNYWVQMFDSYSGTLPLLIIALFEMIAVSYVY 473

Query: 121 GLK 123
           GL 
Sbjct: 474 GLD 476


>gnl|CDD|212086 cd11517, SLC6sbd_B0AT3, glycine transporter, B0AT3; solute-binding
           domain.  B0AT3 (also called Xtrp2, XT2) transports
           glycine. Human B0AT3 is encoded by the SLC6A18 gene.
           B0AT3 is expressed in the kidney. Mutations in the
           SLC6A18 gene may contribute to the autosomal recessive
           disorder iminoglycinuria and its related disorder
           hyperglycinuria. SLC6A18 or its neighboring genes are
           associated with increased susceptibility to myocardial
           infarction. This subgroup belongs to the solute carrier
           6 (SLC6) transporter family.
          Length = 576

 Score =  146 bits (370), Expect = 1e-42
 Identities = 64/121 (52%), Positives = 90/121 (74%), Gaps = 1/121 (0%)

Query: 4   TASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPN 63
           +ASG GLAFI+FTEA+   PGAQ+WAVLFF MLFTLG+ S FG +EGV T ++D+ + P 
Sbjct: 362 SASGPGLAFIVFTEAVLHMPGAQVWAVLFFGMLFTLGLSSMFGNVEGVITPLLDVGVLPR 421

Query: 64  -MRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
            + KE +TG++CL+C + ++ F   +GNY   +FDSF+ +  LL+IAFFE + V Y+YG+
Sbjct: 422 WVPKEALTGLVCLVCFLSALCFTLQSGNYWLEIFDSFAASLNLLVIAFFEVVGVVYVYGI 481

Query: 123 K 123
           K
Sbjct: 482 K 482


>gnl|CDD|215790 pfam00209, SNF, Sodium:neurotransmitter symporter family. 
          Length = 506

 Score =  134 bits (339), Expect = 2e-38
 Identities = 58/119 (48%), Positives = 81/119 (68%), Gaps = 1/119 (0%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDM-KIFPNM 64
           SG GLAFI + EA+   P +  W+VLFFLML TLG+DSQFG +EG+ T++VD   I    
Sbjct: 307 SGPGLAFIAYPEAVTMLPLSPFWSVLFFLMLITLGLDSQFGGVEGIITALVDEFPILLRK 366

Query: 65  RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           R+E+ T I+C++  +I +      G YVF LFD ++ +F LL + FFECIAV+++YGL 
Sbjct: 367 RRELFTLIVCVISFLIGLILVTEGGIYVFTLFDYYAASFGLLFVVFFECIAVAWVYGLD 425


>gnl|CDD|212034 cd10324, SLC6sbd, Solute carrier 6 family, neurotransmitter
           transporters; solute-binding domain.  This family
           represents the solute-binding domain of SLC6 proteins
           (also called the sodium- and chloride-dependent
           neurotransmitter transporter family or Na+/Cl--dependent
           transporter family). These use sodium and chloride
           electrochemical gradients to catalyze the
           thermodynamically uphill movement of a variety of
           substrates, and include neurotransmitter transporters
           (NTTs). The latter are Na+/Cl--dependent plasma membrane
           transporters for the monoamine neurotransmitters
           serotonin (5-hydroxytryptamine), dopamine, and
           norepinephrine, and the amino acid neurotransmitters
           GABA and glycine. NTTs are widely expressed in the
           mammalian brain, and are involved in regulating
           neurotransmitter signaling and homeostasis, through
           facilitating the uptake of released neurotransmitters
           from the extracellular space into neurons and glial
           cells. NTTs are the target of a range of therapeutic
           drugs for the treatment of psychiatric diseases, such as
           major depression, anxiety disorders, attention deficit
           hyperactivity disorder and epilepsy. In addition, they
           are the primary targets of cocaine, amphetamines and
           other psychostimulants. This family also includes
           Drosophila Blot which is expressed primarily in
           epithelial tissues of ectodermal origin and in the
           nervous system of the embryo and larvae, but in addition
           found in the developing oocyte and the freshly laid egg.
           A lack or reduction of Blot function during oogenesis
           results in early arrest of embryonic development. 12
           transmembrane helices (TMs) appears to be common for
           eukaryotic and some prokaryotic and archaeal SLC6s, (a
           core inverted topology repeat, TM1-5 and TM6-10, plus
           TMs11-12; TMs numbered to conform to the SLC6 Aquifex
           aeolicus LeuT), although a majority of bacterial, and
           some archaeal SLC6s lack TM12, for example the
           functional Fusobacterium nucleatum tyrosine transporter
           Tyt1.
          Length = 417

 Score =  132 bits (335), Expect = 3e-38
 Identities = 49/119 (41%), Positives = 76/119 (63%)

Query: 5   ASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM 64
             G GLAF+++ EAI + P  Q+W+VLFF MLF LG+DSQF  +E + T+IVD       
Sbjct: 261 KGGPGLAFVVYPEAIAKMPVPQLWSVLFFFMLFLLGLDSQFAIVETIVTAIVDEFPKLRK 320

Query: 65  RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           RK ++T  +C++  ++ + +    G Y+  L D ++  F LL++A FE IA+S+IYG+ 
Sbjct: 321 RKWLVTLGVCVVGFLLGLPYVTQGGIYILDLLDYYAATFSLLVLALFELIAISWIYGVD 379


>gnl|CDD|212085 cd11516, SLC6sbd_B0AT1, Na(+)-dependent neutral amino acids
           transporter, B0AT1; solute-binding domain.  B0AT1 (also
           called HND) transports neutral amino acids. Human B0AT1
           is encoded by the SLC6A19 gene. B0AT1 is expressed
           primarily in the kidney and intestine; it requires
           collectrin for expression in the kidney, and
           angiotensin-converting enzyme 2 for expression in the
           intestine. Interaction with these two proteins
           implicates B0AT1 in more complex processes such as
           glomerular structure, exocytosis, and blood pressure
           control. The autosomal recessive disorder, Hartnup
           disorder, is caused by mutations in B0AT1. This subgroup
           belongs to the solute carrier 6 (SLC6) transporter
           family.
          Length = 581

 Score =  134 bits (338), Expect = 6e-38
 Identities = 63/117 (53%), Positives = 87/117 (74%), Gaps = 1/117 (0%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFP-NMR 65
           GTGLAFI+FTEAI + P + +W+VLFF+MLF LG+ S FG +EGV   + D+K+ P +  
Sbjct: 364 GTGLAFIVFTEAITKMPLSPLWSVLFFIMLFCLGLSSMFGNMEGVLVPLQDLKVIPKSWP 423

Query: 66  KEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
           KE+ITG++CL+  +I + F  G+GNY   LFDSF+G+ PLLIIAF E  +V Y+YG+
Sbjct: 424 KEIITGLICLVSFLIGLIFVLGSGNYWLALFDSFAGSIPLLIIAFCEMFSVVYVYGI 480


>gnl|CDD|212065 cd11496, SLC6sbd-TauT-like, Na(+)- and Cl(-)-dependent taurine
           transporter TauT, and related proteins; solute-binding
           domain.  This subgroup represents the solute-binding
           domain of TauT-like Na(+)- and Cl(-)-dependent
           transporters. Family members include: human TauT which
           transports taurine, human GAT1, GAT2, and GAT3, and
           BGT1, which transport gamma-aminobutyric acid (GABA),
           and human CT1 which transports creatine. This subgroup
           belongs to the solute carrier 6 (SLC6) transporter
           family.
          Length = 543

 Score =  122 bits (308), Expect = 7e-34
 Identities = 58/125 (46%), Positives = 82/125 (65%), Gaps = 8/125 (6%)

Query: 5   ASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM 64
            SG GLAFI +  A++  P  Q+WAVLFF+ML  LG+DSQF  +EG  T+IVD+  +PN+
Sbjct: 325 ESGPGLAFIAYPRAVSLLPLPQLWAVLFFIMLLLLGLDSQFVGVEGFVTAIVDL--YPNV 382

Query: 65  -----RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGN-FPLLIIAFFECIAVSY 118
                R+E+   I+CL+C +I +      G YVF LFD ++ +   LL +AFFECIA+S+
Sbjct: 383 LRLRYRREIFVAIVCLVCFLIGLPMVTEGGIYVFQLFDYYAASGICLLWLAFFECIAISW 442

Query: 119 IYGLK 123
           +YG  
Sbjct: 443 VYGAD 447


>gnl|CDD|212091 cd11522, SLC6sbd_SBAT1, Sodium-coupled branched-chain amino-acid
           transporter 1; solute-binding domain.  SBAT1 (also
           called B0AT2, v7-3, NTT7-3) is a high-affinity
           Na(+)-dependent transporter for large neutral amino
           acids, including leucine, isoleucine, valine, proline
           and methionine. Human SBAT1 is encoded by the SLC6A15
           gene, a susceptibility gene for major depression. SBAT1
           is expressed in brain, and may have a role in
           transporting neurotransmitter precursors into neurons.
           This subgroup belongs to the solute carrier 6 (SLC6)
           transporter family.
          Length = 580

 Score =  116 bits (293), Expect = 9e-32
 Identities = 59/116 (50%), Positives = 77/116 (66%), Gaps = 3/116 (2%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           GTGLAFI FTEA+  FP +  W+V+FFLML  LG+ S FGT+EG+ T IVD      +RK
Sbjct: 378 GTGLAFIAFTEAMTHFPASPFWSVMFFLMLVNLGLGSMFGTIEGIITPIVDTF---KVRK 434

Query: 67  EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
           E++T I CLL   I + F   +GNY   +FD +S   PLLI+   E IAVS++YG+
Sbjct: 435 EILTVICCLLAFCIGLIFVQRSGNYFVTMFDDYSATLPLLIVVILENIAVSFVYGI 490


>gnl|CDD|212087 cd11518, SLC6sbd_SIT1, Na(+)- and Cl(-)-dependent imino acid
           transporter SIT1; solute-binding domain.  SIT1 (also
           called XTRP3, XT3, IMINO) transports imino acids, such
           as proline, pipecolate, MeAIB, and sarcosine. It has
           weak affinity for neutral amino acids such as
           phenylalanine. Human SIT1 is encoded by the SLC6A20
           gene. SIT1 is expressed in brain, kidney, small
           intestine, thymus, spleen, ovary, and lung. SLC6A20 is a
           candidate gene for the rare disorder iminoglycinuria.
           This subgroup belongs to the solute carrier 6 (SLC6)
           transporter family.
          Length = 576

 Score =  115 bits (290), Expect = 2e-31
 Identities = 51/118 (43%), Positives = 75/118 (63%), Gaps = 1/118 (0%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIF-PNMR 65
           GTGLAFI+++EAI     +Q+W+VL+F ML  LGI S  G    + T + D KI   ++ 
Sbjct: 369 GTGLAFIVYSEAIKNMEVSQLWSVLYFFMLLMLGIGSMLGNTAAILTPLTDSKIISSHLP 428

Query: 66  KEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           KE I+G++C + C+I + F   AGNY F +F+ ++    LL+I   E IAV Y+YGL+
Sbjct: 429 KEAISGLVCFINCIIGLVFTMEAGNYWFDIFNDYAATLSLLLIVLVETIAVCYVYGLR 486


>gnl|CDD|212084 cd11515, SLC6sbd_NTT4-like, Na(+)-dependent neurotransmitter
           transporter 4, and related proteins; solute-binding
           domain.  This subgroup includes the solute-binding
           domain of NTT4 (also called XT1) and SBAT1 (also called
           B0AT2, v7-3, NTT7-3); both these proteins can transport
           neutral amino acids. Human SBAT1 is encoded by the
           SLC6A15 gene, a susceptibility gene for major
           depression. SBAT1 is expressed in brain, and may have a
           role in transporting neurotransmitter precursors into
           neurons. Human NTT4 is encoded by the SLC6A17 gene. NTT4
           is specifically expressed in the nervous system, in
           synaptic vesicles of glutamatergic and GABAergic
           neurons, and may play an important role in synaptic
           transmission. This subgroup belongs to the solute
           carrier 6 (SLC6) transporter family.
          Length = 530

 Score =  111 bits (280), Expect = 4e-30
 Identities = 60/117 (51%), Positives = 79/117 (67%), Gaps = 3/117 (2%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           GTGLAFI FTEA+  FP +  W+V+FFLML  LG+ S FGT+EG+TT IVD      +RK
Sbjct: 328 GTGLAFIAFTEAMTHFPASPFWSVMFFLMLVNLGLGSMFGTIEGITTPIVDTF---KVRK 384

Query: 67  EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           E++T I CL   +I + F   +GNY   +FD +S   PLLI+   E IAV++IYG+K
Sbjct: 385 EILTVICCLFAFLIGLIFVQRSGNYFVTMFDDYSATLPLLIVVILENIAVAWIYGIK 441


>gnl|CDD|212069 cd11500, SLC6sbd_PROT, Na(+)- and Cl(-)-dependent L-proline
           transporter PROT; solute-binding domain.  PROT is a
           high-affinity L-proline transporter that transports
           L-proline, and may have a role in excitatory
           neurotransmission. Human PROT is encoded by the SLC6A7
           gene, a potential susceptible gene for asthma. PROT is
           expressed in the brain. This subgroup belongs to the
           solute carrier 6 (SLC6) transporter family.
          Length = 544

 Score =  106 bits (267), Expect = 3e-28
 Identities = 44/122 (36%), Positives = 73/122 (59%), Gaps = 5/122 (4%)

Query: 5   ASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM 64
            +G GLAF+ + EA+   P +  W++LFF ML TLG+DSQF  LE + T++ D   FP +
Sbjct: 324 DAGPGLAFVAYPEALTLLPVSPFWSILFFFMLLTLGLDSQFAMLETIVTAVTDE--FPYL 381

Query: 65  ---RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYG 121
               K    G++C+   ++ +      G Y   L D +S +F L+++A F C+A+S++YG
Sbjct: 382 LRKYKTWFLGLICVGMYLLGLLLVTDGGMYWLTLMDWYSASFGLMVLALFMCLAISWVYG 441

Query: 122 LK 123
           ++
Sbjct: 442 IQ 443


>gnl|CDD|212078 cd11509, SLC6sbd_CT1, Na(+)- and Cl(-)-dependent creatine
           transporter 1; solute-binding domain.  CT1 (also called
           CRTR, CRT) transports creatine. Human CT1 is encoded by
           the SLC6A8 gene. CT1 is ubiquitously expressed, with
           highest levels found in skeletal muscle and kidney.
           Creatine is absorbed from food or synthesized from
           arginine and plays an important role in energy
           metabolism. Deficiency in human CT1 leads to X-linked
           cerebral creatine transporter deficiency. In males, this
           disorder is characterized by language and speech delays,
           autistic-like behavior, seizures in about 50% of cases,
           and can also involve midfacial hypoplasia, and short
           stature. In females, it is characterized by mild
           cognitive impairment with behavior and learning
           problems. This subgroup belongs to the solute carrier 6
           (SLC6) transporter family.
          Length = 592

 Score =  106 bits (267), Expect = 3e-28
 Identities = 53/120 (44%), Positives = 76/120 (63%), Gaps = 4/120 (3%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDM---KIFP 62
           SG GLAFI + +A+   P A +WA LFF ML  LG+DSQF  +EG  T I+D+   K + 
Sbjct: 337 SGPGLAFIAYPKAVTLMPVAPLWAALFFFMLLLLGLDSQFVGVEGFITGILDLFPQKYYG 396

Query: 63  NMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGN-FPLLIIAFFECIAVSYIYG 121
            +R+E+   + CLLC +I +S     G YVF LFD +S +   LL  AF+EC+ ++++YG
Sbjct: 397 RLRREITAALCCLLCFLIDLSMVTQGGMYVFQLFDYYSASGITLLWQAFWECVVIAWVYG 456


>gnl|CDD|212090 cd11521, SLC6sbd_NTT4, Na(+)-dependent neurotransmitter transporter
           4; solute-binding domain.  NTT4 (also called XT1)
           transports the neutral amino acids, proline, glycine,
           leucine, and alanine, and may play an important role in
           synaptic transmission. Human NTT4 is encoded by the
           SLC6A17 gene. NTT4 is specifically expressed in the
           nervous system, in synaptic vesicles of glutamatergic
           and GABAergic neurons. This subgroup belongs to the
           solute carrier 6 (SLC6) transporter family.
          Length = 589

 Score =  103 bits (258), Expect = 5e-27
 Identities = 54/117 (46%), Positives = 73/117 (62%), Gaps = 3/117 (2%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           GTGLAFI FTEA+  FP +  W+V+FFLML  LG+ S  GT+ G+TT I+D      +RK
Sbjct: 378 GTGLAFIAFTEAMTHFPASPFWSVMFFLMLINLGLGSMIGTMSGITTPIIDTF---KVRK 434

Query: 67  EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           EV T   C+   ++ + F   +GNY   +FD +S   PL I+   E IAV++IYG K
Sbjct: 435 EVFTVGCCIFAFLVGLIFVQRSGNYFVTMFDDYSATLPLTIVVILENIAVAWIYGTK 491


>gnl|CDD|212075 cd11506, SLC6sbd_GAT1, Na(+)- and Cl(-)-dependent GABA transporter
           1; solute-binding domain.  GAT1 transports
           gamma-aminobutyric acid (GABA). GABA is the main
           inhibitory neurotransmitter within the mammalian CNS.
           Human GAT1 is encoded by the SLC6A1 gene. GAT1 is
           expressed in brain and peripheral nervous system. The
           antiepileptic drug, Tiagabine, inhibits GAT1. This
           subgroup belongs to the solute carrier 6 (SLC6)
           transporter family.
          Length = 598

 Score =  102 bits (256), Expect = 9e-27
 Identities = 56/122 (45%), Positives = 81/122 (66%), Gaps = 6/122 (4%)

Query: 5   ASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM 64
           ASG GLAF+ + EA+ Q P + +WAVLFF ML  LGIDSQF T+EG  T++VD   FP +
Sbjct: 357 ASGPGLAFLAYPEAVTQLPISPLWAVLFFSMLLMLGIDSQFCTVEGFITALVDE--FPRL 414

Query: 65  ---RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGN-FPLLIIAFFECIAVSYIY 120
              R+E+   ++C++  +I +S     G YVF LFD +S +   LL + FFEC+++S+ Y
Sbjct: 415 LRNRREIFIAVVCIVSYLIGLSNITQGGIYVFKLFDYYSASGMSLLFLVFFECVSISWFY 474

Query: 121 GL 122
           G+
Sbjct: 475 GV 476


>gnl|CDD|212066 cd11497, SLC6sbd_SERT-like, Na(+)- and Cl(-)-dependent monoamine
           transporters, SERT, NET, DAT1 and related proteins;
           solute binding domain.  This subgroup represents the
           solute-binding domain of transmembrane transporters that
           transport monoamine neurotransmitters from synaptic
           spaces into presynaptic neurons. Members include: NET
           which transports norepinephrine, SERT which transports
           serotonin, and DAT1 which transports dopamine. These
           transporters may play a role in diseases including
           depression, anxiety disorders, attention-deficit
           hyperactivity disorder, and in the control of human
           behavior and emotional states. This subgroup belongs to
           the solute carrier 6 (SLC6) transporter family.
          Length = 539

 Score = 97.8 bits (244), Expect = 6e-25
 Identities = 45/122 (36%), Positives = 68/122 (55%), Gaps = 1/122 (0%)

Query: 3   ATASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVD-MKIF 61
               G GL FI++ EAI   PG+  WA++FFLML TLG+DS FG LE V T + D     
Sbjct: 322 VATEGPGLVFIVYPEAIATLPGSTFWAIIFFLMLITLGLDSTFGGLEAVITGLCDEFPPV 381

Query: 62  PNMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYG 121
              R+E+    + ++C ++++      G YV  L D ++    +L + F E +AVS+ YG
Sbjct: 382 LGKRRELFVLGVVIICFLLALPTVTYGGIYVVTLLDRYAAGTSILFVVFLEAVAVSWFYG 441

Query: 122 LK 123
           + 
Sbjct: 442 VD 443


>gnl|CDD|212070 cd11501, SLC6sbd_ATB0, Na(+)- and Cl(-)-dependent beta-alanine
           transporter ATB0+; solute-binding domain.  ATB0+ (also
           known as the beta-alanine carrier) is a transmembrane
           transporter with a broad substrate specificity; it can
           transport non-alpha-amino acids such as beta-alanine
           with low affinity, and can transport dipolar and
           cationic amino acids such as leucine and lysine, with a
           higher affinity. It may have a role in the absorption of
           essential nutrients and drugs in the distal regions of
           the human gastrointestinal tract. Human ATB0+ is encoded
           by the SLC6A14 gene. ATB0+ is expressed in the lung,
           trachea, salivary gland, mammary gland, stomach, and
           pituitary gland. ATB0+ may play a role in obesity, and
           its upregulation may have a pathogenic role in
           colorectal cancer. This subgroup belongs to the solute
           carrier 6 (SLC6) transporter family.
          Length = 601

 Score = 96.4 bits (240), Expect = 2e-24
 Identities = 46/119 (38%), Positives = 69/119 (57%), Gaps = 5/119 (4%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMR 65
           SG  LAFI + EA+ + P + +W++LFF ML TLG+DSQF  +E +TT+I D   FP + 
Sbjct: 346 SGFDLAFIAYPEALAKLPISPLWSILFFFMLLTLGLDSQFAGIETITTTIQDA--FPKVM 403

Query: 66  KE---VITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYG 121
           K+    IT  +C++  ++ +     AG Y   L D F   + +L  A  E I + +IYG
Sbjct: 404 KKKRIPITLGVCIILFLLGLPCVTQAGIYWVNLIDHFCAGWGILFAAVLELIGIIWIYG 462


>gnl|CDD|212079 cd11510, SLC6sbd_TauT, Na(+)- and Cl(-)-dependent taurine
           transporter; solute-binding domain.  TauT is a Na(+)-
           and Cl(-)-dependent, high-affinity, low-capacity
           transporter of taurine and beta-alanine. Human TauT is
           encoded by the SLC6A6 gene. TauT is expressed in brain,
           retina, liver, kidney, heart, spleen, and pancreas. It
           may play a part in the supply of taurine to the
           intestinal epithelium and in the between-meal-capture of
           taurine. It may also participate in re-absorbing taurine
           that has been deconjugated from bile acids in the distal
           lumen. Functional TauT protects kidney cells from
           nephrotoxicity caused by the chemotherapeutic agent
           cisplatin; cisplatin down-regulates TauT in a
           p53-dependent manner. In mice, TauT has been shown to be
           important for the maintenance of skeletal muscle
           function and total exercise capacity. TauT-/- mice
           develop additional clinically important diseases, some
           of which are characterized by apoptosis, including
           vision loss, olfactory dysfunction, and chronic liver
           disease. This subgroup belongs to the solute carrier 6
           (SLC6) transporter family.
          Length = 542

 Score = 95.3 bits (237), Expect = 5e-24
 Identities = 52/122 (42%), Positives = 78/122 (63%), Gaps = 8/122 (6%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM- 64
           SG GLAFI + +A+   P    WA+LFF+ML  LG+DSQF  +EG  TS+VD+  +P+  
Sbjct: 325 SGPGLAFIAYPKAVTMMPLPTFWAILFFIMLLLLGLDSQFVEVEGQITSLVDL--YPSFL 382

Query: 65  ----RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGN-FPLLIIAFFECIAVSYI 119
               R+E+   I+C +  ++ ++     G YVF LFD ++ +   LL +AFFECIAV+++
Sbjct: 383 RKGYRREIFIAIVCFISYLLGLTMVTEGGMYVFQLFDYYAASGVCLLWVAFFECIAVAWV 442

Query: 120 YG 121
           YG
Sbjct: 443 YG 444


>gnl|CDD|212094 cd11556, SLC6sbd_SERT-like_u1, uncharacterized subgroup of the
           SERT-like Na(+)- and Cl(-)-dependent monoamine
           transporter subfamily; solute binding domain.  SERT-like
           Na(+)- and Cl(-)-dependent monoamine transporters,
           transport monoamine neurotransmitters from synaptic
           spaces into presynaptic neurons. Members include: the
           norepinephrine transporter NET, the serotonin
           transporter SERT , and the dopamine transporter DAT1.
           These latter may play a role in diseases or disorders
           including depression, anxiety disorders, and
           attention-deficit hyperactivity disorder, and in the
           control of human behavior and emotional states. They
           belongs to the solute carrier 6 (SLC6) transporter
           family. Members of this subgroup are uncharacterized.
          Length = 552

 Score = 90.2 bits (224), Expect = 3e-22
 Identities = 48/119 (40%), Positives = 72/119 (60%), Gaps = 4/119 (3%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           G GL F+++ EA++  PG+  W++LFFLML TLG+DS FG  E + T++ D   FP +++
Sbjct: 340 GPGLVFVVYPEALSTMPGSTFWSLLFFLMLMTLGLDSSFGGSEAIITALSDE--FPIIKR 397

Query: 67  --EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
             E+  G L     VI ++     G Y F L D ++  + +LI   FE +AVS+IYGL 
Sbjct: 398 HRELFVGCLFAFYFVIGLAMCTQGGIYFFHLLDRYAAGYSILIAVLFEAVAVSWIYGLD 456


>gnl|CDD|212068 cd11499, SLC6sbd_GlyT2, Na(+)- and Cl(-)-dependent glycine
           transporter GlyT2; solute-binding domain.  GlyT2 (also
           called NET1) is a membrane-bound transporter that
           re-uptakes glycine from the synaptic cleft. Human GlyT2
           is encoded by the SLC6A5 gene. GlyT2 is expressed in
           brain and spinal cord. GlyT2 may play a role in pain,
           and in spasticity. This subgroup belongs to the solute
           carrier 6 (SLC6) transporter family.
          Length = 606

 Score = 89.6 bits (222), Expect = 4e-22
 Identities = 45/120 (37%), Positives = 74/120 (61%), Gaps = 5/120 (4%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM-- 64
           G G+AF+++ EA+ + P +  WA++FFLML TLG+D+ F T+E + TS+ D   FP    
Sbjct: 352 GPGIAFVVYPEALTRLPLSPFWAIIFFLMLLTLGLDTMFATIETIVTSVSDE--FPKYLR 409

Query: 65  -RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
             K + T + C+   ++        G Y+  L D+++ ++ L+IIA FE + +SYIYGL+
Sbjct: 410 THKPLFTLVCCISFFIMGFPMITQGGMYMLQLVDTYAASYSLVIIAIFELVGISYIYGLQ 469


>gnl|CDD|212042 cd10334, SLC6sbd_u1, uncharacterized bacterial and archaeal solute
           carrier 6 subfamily; solute-binding domain.  SLC6
           proteins (also called the sodium- and chloride-dependent
           neurotransmitter transporter family or Na+/Cl--dependent
           transporter family) include neurotransmitter
           transporters (NTTs): these are sodium- and
           chloride-dependent plasma membrane transporters for the
           monoamine neurotransmitters serotonin
           (5-hydroxytryptamine), dopamine, and norepinephrine, and
           the amino acid neurotransmitters GABA and glycine. These
           NTTs are widely expressed in the mammalian brain,
           involved in regulating neurotransmitter signaling and
           homeostasis, and the target of a range of therapeutic
           drugs for the treatment of psychiatric diseases.
           Bacterial members of the SLC6 family include the LeuT
           amino acid transporter.
          Length = 480

 Score = 87.9 bits (219), Expect = 1e-21
 Identities = 43/119 (36%), Positives = 70/119 (58%), Gaps = 4/119 (3%)

Query: 5   ASGTGLAFIIFTEAINQF-PGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPN 63
           +SG GLAF+ F +AIN   PG  ++ VLFFL L   G+ S    +E V +++ D      
Sbjct: 291 SSGIGLAFVAFPKAINLMPPGGALFGVLFFLSLVFAGLTSLISLVEVVISALQDKFGLS- 349

Query: 64  MRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
            RK+ +T I+CL+  ++S+ FA GAG Y+  + D F  N+ ++++   E I V +++G 
Sbjct: 350 -RKKAVT-IVCLVGFLVSLLFATGAGLYLLDIVDHFINNYGIVLVGLVEVIVVGWVFGA 406


>gnl|CDD|212082 cd11513, SLC6sbd_SERT, Na(+)- and Cl(-)-dependent serotonin
           transporter SERT; solute-binding domain.  SERT (also
           called 5-HTT), is a transmembrane transporter that
           transports the neurotransmitter serotonin from synaptic
           spaces into presynaptic neurons. The antiport of a K+
           ion is believed to follow the transport of serotonin and
           promote the reorientation of SERT for another transport
           cycle. Human SERT is encoded by the SLC6A4 gene. SERT is
           expressed in brain, peripheral nervous system, placenta,
           epithelium, and platelets. SERT may play a role in
           diseases or disorders including anxiety, depression,
           autism, gastrointestinal disorders, premature
           ejaculation, and obesity. It may also have a role in
           social cognition. This subgroup belongs to the solute
           carrier 6 (SLC6) transporter family.
          Length = 537

 Score = 86.0 bits (213), Expect = 7e-21
 Identities = 45/122 (36%), Positives = 72/122 (59%), Gaps = 3/122 (2%)

Query: 3   ATASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDM--KI 60
           AT +G  L FI + EAI   PG+  +A++FFLM+ TLG+DS FG LEGV T+++D    +
Sbjct: 320 ATDAGPSLLFITYAEAIANMPGSTFFAIIFFLMIITLGLDSTFGGLEGVITAVLDEFPHV 379

Query: 61  FPNMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIY 120
               R+  + G++  +C + S++     G YV  L + ++    +L +   E IAVS+ Y
Sbjct: 380 IGKRREIFVLGLVI-VCFLGSLATLTFGGAYVVKLLEEYATGPAVLTVVLLEAIAVSWFY 438

Query: 121 GL 122
           G+
Sbjct: 439 GI 440


>gnl|CDD|212083 cd11514, SLC6sbd_DAT1, Na(+)- and Cl(-)-dependent dopamine
           transporter 1; solute-binding domain.  DAT1 (also called
           DAT), is a plasma membrane transport protein that
           functions at the dopaminergic synapses to transport
           dopamine from the extracellular space back into the
           presynaptic nerve terminal. Human DAT1 is encoded by the
           SLC6A3 gene, and is expressed in the brain. DAT1 may
           play a role in diseases or disorders related to
           dopaminergic neurons, including attention-deficit
           hyperactivity disorder (ADHD), Tourette syndrome,
           Parkinson's disease, alcoholism, drug abuse,
           schizophrenia, extraversion, and risky behavior. This
           subgroup belongs to the solute carrier 6 (SLC6)
           transporter family.
          Length = 555

 Score = 85.8 bits (212), Expect = 8e-21
 Identities = 46/116 (39%), Positives = 66/116 (56%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           G GL FII+ EAI   P + +WAV+FF+ML TLGIDS  G +E V T ++D   F +  +
Sbjct: 327 GPGLIFIIYPEAIATLPLSSVWAVIFFIMLLTLGIDSAMGGMESVITGLIDEFKFLHRHR 386

Query: 67  EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
           E+ T  + L   +IS+      G YVF L D F+    +L     E I +++ YG+
Sbjct: 387 ELFTLFIVLSTFLISLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGIAWFYGV 442


>gnl|CDD|212077 cd11508, SLC6sbd_GAT3, Na(+)- and Cl(-)-dependent GABA transporter
           3; solute-binding domain.  This family includes human
           GAT3 (hGAT3) a high-affinity transporter of
           gamma-aminobutyric acid (GABA). GABA is the main
           inhibitory neurotransmitter within the mammalian CNS.
           hGAT3 is encoded by the SLC6A11 gene, and is similar to
           mouse GAT4, and rat GAT3/GATB. GAT3 is expressed
           primarily in the glia of the brain, and is a potential
           drug target for antiepileptic drugs. This subgroup
           belongs to the solute carrier 6 (SLC6) transporter
           family.
          Length = 542

 Score = 85.4 bits (211), Expect = 1e-20
 Identities = 48/120 (40%), Positives = 74/120 (61%), Gaps = 4/120 (3%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDM--KIF-P 62
           SG GLAFI + +A+   P + +WA LFF+ML  LG+DSQF  +E + T++VDM  K+F  
Sbjct: 325 SGPGLAFIAYPKAVTMMPLSPLWATLFFMMLIFLGLDSQFVCVESLVTAVVDMYPKVFRR 384

Query: 63  NMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSF-SGNFPLLIIAFFECIAVSYIYG 121
             R+E++   L ++   + +      G Y+F LFDS+ +    LL +A FECI + ++YG
Sbjct: 385 GYRRELLILALSIVSYFLGLVMLTEGGMYIFQLFDSYAASGMCLLFVAIFECICIGWVYG 444


>gnl|CDD|212092 cd11554, SLC6sbd_u2, uncharacterized eukaryotic solute carrier 6
           subfamily; solute-binding domain.  SLC6 proteins (also
           called the sodium- and chloride-dependent
           neurotransmitter transporter family or Na+/Cl--dependent
           transporter family) include neurotransmitter
           transporters (NTTs): these are sodium- and
           chloride-dependent plasma membrane transporters for the
           monoamine neurotransmitters serotonin
           (5-hydroxytryptamine), dopamine, and norepinephrine, and
           the amino acid neurotransmitters GABA and glycine. These
           NTTs are widely expressed in the mammalian brain, and
           are involved in regulating neurotransmitter signaling
           and homeostasis, and are the target of a range of
           therapeutic drugs for the treatment of psychiatric
           diseases. Bacterial members of the SLC6 family include
           the LeuT amino acid transporter.
          Length = 406

 Score = 82.8 bits (205), Expect = 8e-20
 Identities = 39/113 (34%), Positives = 62/113 (54%)

Query: 10  LAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRKEVI 69
           L F+ + EAI Q PG+  +AVLFFL LF LGI S F  LE V T I D      +++  I
Sbjct: 261 LGFVTYPEAIAQMPGSNFFAVLFFLTLFLLGISSAFALLEAVVTLICDSGWGRKVKRWWI 320

Query: 70  TGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGL 122
             ++C +  ++S+ +    G Y+    D++  N  L+ + + EC+A + +Y  
Sbjct: 321 ATVVCFVSFLLSLPYCTRFGYYLLDAVDAWISNVALVFVVWAECVAATTVYRF 373


>gnl|CDD|212080 cd11511, SLC6sbd_BGT1, Na(+)- and Cl(-)-dependent betaine/GABA
           transporter-1, and related proteins; solute-binding
           domain.  BGT1 is a relatively low-affinity transporter
           of gamma-aminobutyric acid (GABA), and can also
           transport betaine. GABA is the main inhibitory
           neurotransmitter within the mammalian CNS. Human BGT1 is
           encoded by the SLC6A12 gene, and is similar to mouse
           GAT2. Mouse GAT2 plays a role in transporting GABA
           across the blood-brain barrier. In addition to being
           expressed in cells of the central nervous system, BGT1
           is expressed in peripheral tissues, including kidney,
           liver, and heart. An association has been shown between
           the SLC6A12 gene and the occurrence of
           aspirin-intolerant asthma, and BGT1 is a drug target for
           antiepileptic drugs. This subgroup belongs to the solute
           carrier 6 (SLC6) transporter family.
          Length = 541

 Score = 82.3 bits (203), Expect = 1e-19
 Identities = 46/122 (37%), Positives = 73/122 (59%), Gaps = 8/122 (6%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM- 64
           SG GLAFI +  A+   P +Q+W+ LFFLML  LG+DSQF  +E + T+ +DM  FP + 
Sbjct: 324 SGPGLAFIAYPTAVTMMPVSQLWSCLFFLMLIFLGLDSQFVCVESMVTASIDM--FPGVF 381

Query: 65  ----RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSF-SGNFPLLIIAFFECIAVSYI 119
               R+E++   + ++C ++ +      G Y+F LFD + +    LL +A FE I + ++
Sbjct: 382 RKKGRRELLILAIAVICYLLGLLLVTEGGMYIFQLFDYYAASGTCLLFLAIFEVICIGWV 441

Query: 120 YG 121
           YG
Sbjct: 442 YG 443


>gnl|CDD|212076 cd11507, SLC6sbd_GAT2, Na(+)- and Cl(-)-dependent GABA transporter
           2; solute-binding domain.  This family includes human
           GAT2 (hGAT2) which transports gamma-aminobutyric acid
           (GABA). GABA is the main inhibitory neurotransmitter
           within the mammalian CNS. hGAT2 is encoded by the
           SLC6A13 gene, and is similar to mouse GAT-3, and rat
           GAT2. hGAT2 is expressed in brain, kidney, lung, and
           testis. hGAT2 is a potential drug target for treatment
           of epilepsy. This subgroup belongs to the solute carrier
           6 (SLC6) transporter family.
          Length = 544

 Score = 76.4 bits (188), Expect = 2e-17
 Identities = 42/124 (33%), Positives = 74/124 (59%), Gaps = 8/124 (6%)

Query: 6   SGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM- 64
           SG GLAFI +  A++  P + +WA  FF+M+  LG+DSQF  +E + T++VDM  +P + 
Sbjct: 322 SGPGLAFIAYPRAVSMMPFSPLWACFFFIMIVLLGLDSQFVCVESLVTAMVDM--YPEVF 379

Query: 65  ----RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGN-FPLLIIAFFECIAVSYI 119
               R+E++   + ++  ++ +      G YVF LFD ++ +   LL +A FE + ++++
Sbjct: 380 RKKNRRELLILFVSIVSFLVGLIMLTEGGMYVFQLFDYYAASGMCLLFVAIFETLCIAWV 439

Query: 120 YGLK 123
           YG  
Sbjct: 440 YGAD 443


>gnl|CDD|212081 cd11512, SLC6sbd_NET, Na(+)- and Cl(-)-dependent norepinephrine
           transporter NET; solute-binding domain.  NET (also
           called NAT1, NET1), is a transmembrane transporter that
           transports the neurotransmitter norepinephrine from
           synaptic spaces into presynaptic neurons. Human NET is
           encoded by the SLC6A2 gene. NET is expressed in brain,
           peripheral nervous system, adrenal gland, and placenta.
           NET may play a role in diseases or disorders including
           depression, orthostatic intolerance, anorexia nervosa,
           cardiovascular diseases, alcoholism, and
           attention-deficit hyperactivity disorder. This subgroup
           belongs to the solute carrier 6 (SLC6) transporter
           family.
          Length = 560

 Score = 74.2 bits (182), Expect = 1e-16
 Identities = 48/123 (39%), Positives = 62/123 (50%), Gaps = 14/123 (11%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIV-DMKIFPNMR 65
           G GL FI++ EAI+   G+  WAV+FF+ML TLGIDS  G +E V T +  D  I    R
Sbjct: 328 GAGLVFILYPEAISTLSGSTFWAVVFFIMLLTLGIDSSMGGMEAVITGLADDFSILKKHR 387

Query: 66  K------EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYI 119
           K        IT +L L C           G YV  L D+F+    +L     E I VS+ 
Sbjct: 388 KLFTFGVAFITFLLALFCIT-------NGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWF 440

Query: 120 YGL 122
           YG+
Sbjct: 441 YGV 443


>gnl|CDD|212071 cd11502, SLC6sbd_NTT5, Neurotransmitter transporter 5;
           solute-binding domain.  Human NTT5 is encoded by the
           SLC6A16 gene. NTT5 is expressed in testis, pancreas, and
           prostate; its expression is predominantly intracellular,
           indicative of a vesicular location. Its substrates are
           unknown. This subgroup belongs to the solute carrier 6
           (SLC6) transporter family.
          Length = 543

 Score = 72.4 bits (178), Expect = 4e-16
 Identities = 39/117 (33%), Positives = 67/117 (57%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNMRK 66
           G G AF+ F+EAI+  PG+  WA++FFL L   G+ + FG ++G+ T + D   F     
Sbjct: 346 GPGFAFLAFSEAISLAPGSAFWAIVFFLALLLAGLSTMFGIMQGIYTPLQDTFSFFRKHP 405

Query: 67  EVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
           +++T ++C+   +  + F   +G+Y   L D +    P++ I  FE IA+++ YG K
Sbjct: 406 KLLTVLVCVGLFLGGLVFTQPSGSYFRSLLDDYLVPLPIIFIVVFENIALAWAYGAK 462


>gnl|CDD|212067 cd11498, SLC6sbd_GlyT1, Na(+)- and Cl(-)-dependent glycine
           transporter GlyT1; solute-binding domain.  GlyT1 is a
           membrane-bound transporter that re-uptakes glycine from
           the synaptic cleft. Human GlyT1 is encoded by the SLC6A9
           gene. GlyT1 is expressed in brain, pancreas, uterus,
           stomach, spleen, liver, and retina. GlyT1 may play a
           role in schizophrenia. This subgroup belongs to the
           solute carrier 6 (SLC6) transporter family.
          Length = 585

 Score = 71.5 bits (175), Expect = 9e-16
 Identities = 41/119 (34%), Positives = 70/119 (58%), Gaps = 2/119 (1%)

Query: 7   GTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDM--KIFPNM 64
           G GLAF+ + EA+   P + +W++LFF ML  LG+ +QF  LE + T++VD     +   
Sbjct: 354 GPGLAFVAYPEALTLLPISPLWSLLFFFMLILLGLGTQFCLLETLVTAVVDEIGNDWIIR 413

Query: 65  RKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYGLK 123
            K  +T  + ++  ++ +     AG Y  +L D+++ +F L+II+   CIA+ YIYG +
Sbjct: 414 NKTYVTLGVAIIGFLLGIPLTTQAGIYWLLLMDNYAASFSLVIISCIMCIAIMYIYGHR 472


>gnl|CDD|223805 COG0733, COG0733, Na+-dependent transporters of the SNF family
           [General function prediction only].
          Length = 439

 Score = 61.1 bits (149), Expect = 4e-12
 Identities = 28/123 (22%), Positives = 54/123 (43%), Gaps = 3/123 (2%)

Query: 1   MAATASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKI 60
            A  + G GL FI+     NQ P   ++ +LFFL+L    + S    LE +  +++D   
Sbjct: 277 GADASQGPGLVFIVLPAVFNQMPLGTLFGILFFLLLLFAALTSAISMLEVLVAALIDKF- 335

Query: 61  FPNMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIY 120
              + ++  T ++ +L  ++ +      G  +F L D    N  + + A    I V ++ 
Sbjct: 336 --GISRKKATWLIGILIFLLGIPSILSFGLSIFDLVDFVVSNILMPLGALLIAIFVGWVL 393

Query: 121 GLK 123
             +
Sbjct: 394 KKE 396


>gnl|CDD|212043 cd10336, SLC6sbd_Tyt1-Like, solute carrier 6 subfamily,
           Fusobacterium nucleatum Tyt1-like; solute-binding
           domain.  SLC6 proteins (also called the sodium- and
           chloride-dependent neurotransmitter transporter family
           or Na+/Cl--dependent transporter family) include
           neurotransmitter transporters (NTTs): these are sodium-
           and chloride-dependent plasma membrane transporters for
           the monoamine neurotransmitters serotonin
           (5-hydroxytryptamine), dopamine, and norepinephrine, and
           the amino acid neurotransmitters GABA and glycine. These
           NTTs are widely expressed in the mammalian brain,
           involved in regulating neurotransmitter signaling and
           homeostasis, and the target of a range of therapeutic
           drugs for the treatment of psychiatric diseases.
           Bacterial members of the SLC6 family include the LeuT
           amino acid transporter. An arrangement of 12
           transmembrane (TM) helices appears to be as a common
           topological motif for eukaryotic and some prokaryotic
           and archaeal NTTs. However, this subfamily which
           contains the majority of bacterial members and some
           archaeal members, appears to contain only 11 TMs; for
           example the functional Fusobacterium nucleatum tyrosine
           transporter Tyt1.
          Length = 439

 Score = 54.4 bits (132), Expect = 8e-10
 Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 6/123 (4%)

Query: 5   ASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIFPNM 64
           A+G GL FI       Q PG +++ +LFFL+L    + S    LE     ++D   +   
Sbjct: 277 AAGPGLLFITLPAVFAQMPGGRLFGILFFLLLLFAALTSAISLLEVPVAYLIDEFGWSRK 336

Query: 65  RKEVITGILCLLCCVIS------MSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSY 118
           +  +I GI+  L  + S      +S     G  +F L D    N  L +      I V +
Sbjct: 337 KATLIVGIIIFLLGIPSALSFGVLSDPTIFGKTIFDLLDFLVSNILLPLGGLLIAIFVGW 396

Query: 119 IYG 121
           + G
Sbjct: 397 VLG 399


>gnl|CDD|212041 cd10333, LeuT-like_sbd, Aquifex aeolicus LeuT and related proteins;
           solute binding domain.  LeuT is a bacterial amino acid
           transporter with specificity for the hydrophobic amino
           acids glycine, alanine, methionine, and leucine. This
           subgroup belongs to the solute carrier 6 (SLC6)
           transporter family; LeuT has been used as a structural
           template for understanding fundamental aspects of SLC6
           function. It has an arrangement of 12 transmembrane
           helices (TMs), which appears to be a common motif for
           eukaryotic and some prokaryotic and archaeal SLC6s: an
           inverted topology repeat: TMs1-5 and TMs6-10, and
           TMs11-12.
          Length = 500

 Score = 40.7 bits (96), Expect = 5e-05
 Identities = 31/122 (25%), Positives = 47/122 (38%), Gaps = 2/122 (1%)

Query: 2   AATASGTGLAFIIFTEAINQFPGAQIWAVLFFLMLFTLGIDSQFGTLEGVTTSIVDMKIF 61
            A A   GL FI      +Q PG Q +  L+F +LF  GI S    L+ +   + +    
Sbjct: 293 VAKAGTFGLGFIALPNVFSQMPGGQFFGFLWFFLLFFAGITSSIAMLQPLIAFLEEE--L 350

Query: 62  PNMRKEVITGILCLLCCVISMSFAHGAGNYVFILFDSFSGNFPLLIIAFFECIAVSYIYG 121
              RK     I  L+  V                 D + G   L+++   E I  ++I+G
Sbjct: 351 KWSRKHAALWIFALVIIVGLPVAFEFIDLKALDELDFWVGTILLVVLGLIEVIVFAWIFG 410

Query: 122 LK 123
            K
Sbjct: 411 AK 412


>gnl|CDD|233186 TIGR00920, 2A060605, 3-hydroxy-3-methylglutaryl-coenzyme A
           reductase.  [Transport and binding proteins,
           Carbohydrates, organic alcohols, and acids].
          Length = 889

 Score = 33.7 bits (77), Expect = 0.015
 Identities = 21/59 (35%), Positives = 30/59 (50%), Gaps = 5/59 (8%)

Query: 67  EVITGILCLLCCVISMSFAHGAG-----NYVFILFDSFSGNFPLLIIAFFECIAVSYIY 120
           EVI G L L  C++SM+   G G     NY    F+    +  ++++    CIAV YIY
Sbjct: 19  EVIVGTLTLTICMLSMNMFTGLGKICGWNYECPKFEEDVLSSDIIVMTITRCIAVLYIY 77


>gnl|CDD|218184 pfam04632, FUSC, Fusaric acid resistance protein family.  This
           family includes a conserved region found in two proteins
           associated with fusaric acid resistance,from
           Burkholderia cepacia and Klebsiella oxytoca. These
           proteins are likely to be membrane transporter proteins.
          Length = 649

 Score = 27.2 bits (61), Expect = 2.3
 Identities = 11/53 (20%), Positives = 18/53 (33%), Gaps = 3/53 (5%)

Query: 45  FGTLEGVTTSIVDMKIFPNMRKEVITGILCLL--CCVISMSFAHGAGNYVFIL 95
            GTL G   ++  + +F      +    L L    C           +Y F+L
Sbjct: 54  LGTLVGAAAAVALVALFVQAP-LLFLLALALWIGLCTALSLLDRNFRSYAFVL 105


>gnl|CDD|235720 PRK06156, PRK06156, hypothetical protein; Provisional.
          Length = 520

 Score = 26.9 bits (60), Expect = 3.6
 Identities = 8/27 (29%), Positives = 14/27 (51%), Gaps = 4/27 (14%)

Query: 37  FTLGIDSQFGTLEGVTTSIVDMKIFPN 63
              G+D++   + G T +    K+FPN
Sbjct: 451 HFTGLDAKPVAIAGSTNA----KLFPN 473


>gnl|CDD|147298 pfam05041, Pecanex_C, Pecanex protein (C-terminus).  This family
           consists of C terminal region of the pecanex protein
           homologues. The pecanex protein is a maternal-effect
           neurogenic gene found in Drosophila.
          Length = 232

 Score = 25.9 bits (57), Expect = 5.2
 Identities = 9/38 (23%), Positives = 17/38 (44%), Gaps = 4/38 (10%)

Query: 73  LCLLCCVI----SMSFAHGAGNYVFILFDSFSGNFPLL 106
           LCLL        S + +    ++++ L   F G+F + 
Sbjct: 20  LCLLGRRALGTASHNMSKSLESFLYGLHALFKGDFRIT 57


>gnl|CDD|176735 cd08320, Pyrin_NALPs, Pyrin death domain found in NALP proteins. 
          Pyrin Death Domain found in NALP (NACHT, LRR and PYD
          domains) proteins including NALP1 (CARD7, NLRP1), NALP3
          (NLRP3, Cryopyrin, CIAS1), and NALP12 (NLRP12,
          Monarch-1), among others. Mammals contains at least 14
          NALP proteins, named NALP1-14 (or NLRP1-14). NALPs are
          members of the NBS-LRR family of proteins possessing a
          tripartite domain structure including a C-terminal LRR
          (leucine-rich repeats), a central nucleotide-binding
          site (NBS) domain or NACHT (for neuronal apoptosis
          inhibitor protein, CIITA, HET-E and TP1), and an
          N-terminal protein-protein interaction domain, which is
          a Pyrin domain in the case of NALPs. The NBS-LRR family
          is also referred to as the NLR (Nod-like Receptor) or
          CATERPILLER (for CARD, transcription enhancer,
          R-(purine)-binding, pyrin, lots of LRRs) family. NALP1
          contains an additional Caspase activation and
          recruitment domain (CARD) at the C-terminus. NALP1 and
          NALP3 are both involved in the assembly of the
          'inflammasome', a multiprotein platform which is formed
          in response to infection or injury and is responsible
          for caspase-1 activation and regulation of IL-1beta
          maturation. NALP1-inflammasomes recognize specific
          substances while NALP3-inflammasomes responds to many
          diverse triggers. Mutations in the NALP3 gene are
          associated with a broad spectrum of autoinflammatory
          disorders including Muckle-Wells Syndrome (MWS),
          familial cold autoinflammatory syndrome (FCAS), and
          chronic neurologic cutaneous and articular syndrome
          (CINCA). NALP12 functions as a negative regulator of
          inflammation. In general, Pyrin is a subfamily of the
          Death Domain (DD) superfamily and functions in several
          signaling pathways. DDs are protein-protein interaction
          domains found in a variety of domain architectures.
          Their common feature is that they form homodimers by
          self-association or heterodimers by associating with
          other members of the DD superfamily including CARD and
          DED (Death Effector Domain). They serve as adaptors in
          signaling pathways and can recruit other proteins into
          signaling complexes.
          Length = 86

 Score = 25.3 bits (56), Expect = 5.5
 Identities = 8/29 (27%), Positives = 12/29 (41%), Gaps = 4/29 (13%)

Query: 4  TASGTGLAFIIFTEAINQFPGAQIWAVLF 32
           A G  LA ++    +  + G Q W V  
Sbjct: 41 KADGEDLAELL----VEHYGGQQAWDVTL 65


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.334    0.146    0.452 

Gapped
Lambda     K      H
   0.267   0.0736    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 6,413,438
Number of extensions: 578545
Number of successful extensions: 1397
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1357
Number of HSP's successfully gapped: 112
Length of query: 123
Length of database: 10,937,602
Length adjustment: 85
Effective length of query: 38
Effective length of database: 7,167,512
Effective search space: 272365456
Effective search space used: 272365456
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 39 (21.6 bits)
S2: 53 (24.2 bits)